Skip to main content

Ph.D, M.Pharm, MSc Openings at NIPER

National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an autonomous institute of National importance and the first national pharma institute in NE India set up by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India by an act of parliament, to impart high quality Education & Research in the area of Pharmaceutical Sciences.

Production OSD Jobs at Mankind Pharma | D.Pharm, B.Pharm

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

M.Pharm Job under RUSA-MHRD funded research project

Mohanlal Sukhadia University (erstwhile Udaipur University) at Udaipur is a State University established by an Act in the year 1962 to cater the needs of higher education in Southern Rajasthan with more then 2.25 Lakh Students. The University is located in Aravalli Hill Area largely dominated by tribal populations. Endowed with rich cultural heritage, natural resources and beautiful landscape, Udaipur is a world renowned tourist attraction.

Faculty Recruitment in Shirpur Education Society

R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur was established in June 1992 with the aim to enhance the quality education in the field of Pharmacy and empower the quality pharmacist so that they serve the society to develop lifesaving drugs.

Walk in Interview for Production Formulation Manufacturing & Packing at Macleods Pharmaceuticals Ltd

Macleods Pharmaceuticals Ltd. Is one of India's fastest growing pharmaceutical company & ranked amongst the top 10 companies in India with strong R&D and manufacturing sites approved by USFDA, UKMHRA & WHO Geneva.

Job for M.Pharm, MSc in Production at Virchow Biotech

VBPL is an ISO 13485:2012 and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. We also have offices located in USA. Innovative, ever motivated Research team and uncompromising manufacturing team in providing quality products are our strengths.

Post : Executive or Sr Executive

Job in Warehouse at Virchow Biotech Pvt Ltd

VBPL is an ISO 13485:2012 and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. We also have offices located in USA. Innovative, ever motivated Research team and uncompromising manufacturing team in providing quality products are our strengths.

OSD Production Operators Jobs at Hyderabad | 30 Posts

OSD Production Operators Jobs at Hyderabad | 30 Posts

Leading Pharmaceutical recruitment consultancy in Hyderabad.

Post : OSD Production Operators

New research reveals that tinnitus, a common condition that causes the perception of noise in the ear and head, is being exacerbated by COVID-19 – as well as the measures helping to keep us safe.

The study of 3,103 people with tinnitus was led by Anglia Ruskin University (ARU), with support from the British Tinnitus Association and the American Tinnitus Association. The study involved participants from 48 countries, with the vast majority coming from the UK and the US.

Published in the journal Frontiers in Public Health, the research found that 40% of those displaying symptoms of COVID-19 simultaneously experience a worsening of their tinnitus.


Although the study focused on people with pre-existing tinnitus, a small number of participants also reported that their condition was initially triggered by developing COVID-19 symptoms, suggesting that tinnitus could be a ‘long COVID’ symptom in some cases.

Tinnitus affects an estimated one in eight adults in the UK and is associated with reduced emotional wellbeing, depression, and anxiety.


The new study also found that a large proportion of people believe their tinnitus is being made worse by social distancing measures introduced to help control the spread of the virus. These measures have led to significant changes to work and lifestyle routines.

UK respondents reported this to be a greater issue compared to people from other countries, with 46% of UK respondents saying that lifestyle changes had negatively impacted their tinnitus compared to 29% in North America.

Internal worries such as fear of catching COVID-19, financial concerns, loneliness and trouble sleeping have contributed to making tinnitus more bothersome for 32% of people overall, with external factors such as increased videocalls, noisier home environments, home schooling and increased coffee and alcohol consumption also cited by respondents. Females and the under-50s found tinnitus significantly more bothersome during the pandemic.

The study noted that as well as increasing the severity of tinnitus symptoms, the COVID-19 pandemic has also made it more difficult for people to access healthcare support for the condition. This could further increase emotional distress and worsen tinnitus symptoms, creating a vicious cycle. Before COVID-19, more than eight out of 10 UK patients were already unhappy with the treatment options available from their health professional.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Subscribe to